Enorama Pharma
2,26
SEK
-12,74 %
Mindre end 1K følgere
ERMA
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Ownership
Investor consensus
-12,74%
-15,67%
+0,44%
-32,74%
-34,68%
-3%
-80,77%
-92,93%
-64,51%
Enorama Pharma is a pharmaceutical company. The company's operations are focused on producing and developing medical nicotine chewing gum. The products are mainly sold through retailers who sell the product under their own brand. The largest market is established in the Nordic region, but also worldwide. Enorama Pharma was founded in 2006 and the head office is located in Malmö.
Læs mereMarkedsværdi
151,73 mio. SEK
Aktieomsætning
1,78 t SEK
Omsætning
15,77 mio.
EBIT %
-301,33 %
P/E
-
Udbytteafkast, %
-
Finanskalender
20.8
2025
Delårsrapport Q2'25
19.11
2025
Delårsrapport Q3'25
18.2
2026
Årsrapport '25
Alle
Selskabsmeddelelser
ViserAlle indholdstyper
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools